Literature DB >> 16505159

Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.

R Dawes, B Hennig, W Irving, S Petrova, S Boxall, V Ward, D Wallace, D C Macallan, M Thursz, A Hill, W Bodmer, P C L Beverley, E Z Tchilian.   

Abstract

BACKGROUND: A polymorphism in exon 4 (C77G) of CD45 that alters CD45 splicing has been associated with autoimmune and infectious diseases in humans.
OBJECTIVE: To investigate the effect of C77G in hepatitis C virus (HCV) infected individuals and study the phenotype and function of peripheral blood mononuclear cells (PBMC) from healthy and hepatitis C infected C77G carriers.
RESULTS: C77G individuals showed an increased proportion of primed CD45RA and effector memory CD8 T cells and more rapid activation of the lymphocyte specific protein tyrosine kinase (Lck) following CD3 stimulation. Transgenic mice with CD45 expression mimicking that in human C77G variants had more activated/memory T cells, more rapid proliferative responses, and activation of Lck.
CONCLUSIONS: Changes in CD45 isoform expression can alter immune function in human C77G variants and CD45 transgenic mice. The C77G allele may influence the outcome of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505159      PMCID: PMC2564592          DOI: 10.1136/jmg.2005.040485

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  35 in total

1.  A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer.

Authors:  K W Lynch; A Weiss
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

2.  Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old.

Authors:  Qin Ouyang; Wolfgang M Wagner; Anders Wikby; Steffen Walter; Geraldine Aubert; Anthony I Dodi; Paul Travers; Graham Pawelec
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

3.  Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.

Authors:  C Kung; J T Pingel; M Heikinheimo; T Klemola; K Varkila; L I Yoo; K Vuopala; M Poyhonen; M Uhari; M Rogers; S H Speck; T Chatila; M L Thomas
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

Review 4.  CD45: new jobs for an old acquaintance.

Authors:  J M Penninger; J Irie-Sasaki; T Sasaki; A J Oliveira-dos-Santos
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

5.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

6.  A point mutation in PTPRC is associated with the development of multiple sclerosis.

Authors:  M Jacobsen; D Schweer; A Ziegler; R Gaber; S Schock; R Schwinzer; K Wonigeit; R B Lindert; O Kantarci; J Schaefer-Klein; H I Schipper; W H Oertel; F Heidenreich; B G Weinshenker; N Sommer; B Hemmer
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

7.  PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.

Authors:  L F Barcellos; S Caillier; L Dragone; M Elder; E Vittinghoff; P Bucher; R R Lincoln; M Pericak-Vance; J L Haines; A Weiss; S L Hauser; J R Oksenberg
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

8.  A deletion in the gene encoding the CD45 antigen in a patient with SCID.

Authors:  E Z Tchilian; D L Wallace; R S Wells; D R Flower; G Morgan; P C Beverley
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

9.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

Authors:  M Thursz; R Yallop; R Goldin; C Trepo; H C Thomas
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

10.  Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.

Authors:  Michaela Lucas; Ana L Vargas-Cuero; Georg M Lauer; Eleanor Barnes; Christian B Willberg; Nasser Semmo; Bruce D Walker; Rodney Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

View more
  12 in total

1.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

2.  Combinatorial control of signal-induced exon repression by hnRNP L and PSF.

Authors:  Alexis A Melton; Jason Jackson; Jiarong Wang; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

Review 3.  Covalent inhibition of protein tyrosine phosphatases.

Authors:  Kasi Viswanatharaju Ruddraraju; Zhong-Yin Zhang
Journal:  Mol Biosyst       Date:  2017-06-27

4.  Unusual case presentations associated with the CD45 C77G polymorphism.

Authors:  E Z Tchilian; J Gil; M L Navarro; E Fernandez-Cruz; H Chapel; S Misbah; B Ferry; H Renz; R Schwinzer; P C L Beverley
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 5.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

6.  Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.

Authors:  A Windhagen; D Sönmez; H T Hornig-Do; A Kalinowsky; R Schwinzer
Journal:  Clin Exp Immunol       Date:  2007-09-28       Impact factor: 4.330

7.  A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.

Authors:  Justin D Topp; Jason Jackson; Alexis A Melton; Kristen W Lynch
Journal:  RNA       Date:  2008-08-21       Impact factor: 4.942

Review 8.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

9.  Role of host genetic factors in the outcome of hepatitis C virus infection.

Authors:  Bertram Bengsch; Robert Thimme; Hubert E Blum
Journal:  Viruses       Date:  2009-08-05       Impact factor: 5.818

10.  The genetic structure and adaptation of Andean highlanders and Amazonians are influenced by the interplay between geography and culture.

Authors:  Víctor Borda; Isabela Alvim; Marla Mendes; Carolina Silva-Carvalho; Giordano B Soares-Souza; Thiago P Leal; Vinicius Furlan; Marilia O Scliar; Roxana Zamudio; Camila Zolini; Gilderlanio S Araújo; Marcelo R Luizon; Carlos Padilla; Omar Cáceres; Kelly Levano; César Sánchez; Omar Trujillo; Pedro O Flores-Villanueva; Michael Dean; Silvia Fuselli; Moara Machado; Pedro E Romero; Francesca Tassi; Meredith Yeager; Timothy D O'Connor; Robert H Gilman; Eduardo Tarazona-Santos; Heinner Guio
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-04       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.